Position history for UBS Group AG's holdings in AVALO THERAPEUTICS INC
UBS Group AG holds 1.1M shares of AVTX (AVALO THERAPEUTICS INC), worth $17M as of 2026-Q1. The position was increased (+139.0% shares). AVTX represents 0.0% of UBS Group AG's portfolio.
Current Value
$17M
Current Shares
1.1M
Total Value Change
+$17M
Total Shares Change
+1.1M
Other major holders of AVTX: FMR LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., FARALLON CAPITAL MANAGEMENT LLC
Increased |
| 1.1M |
+139.0% |
| $17M |
| 0.0% |
| $18.85 |
46 |
| 2025-Q4 | Increased | 477,816 | +956.9% | $8.7M | 0.0% | $17.81 | 44 |
| 2025-Q3 | Decreased | 45,208 | -46.0% | $574,594 | 0.0% | $13.02 | 0 |
| 2025-Q2 | Decreased | 83,724 | -15.4% | $417,783 | 0.0% | $4.78 | 0 |
| 2025-Q1 | Increased | 98,951 | +0.4% | $792,598 | 0.0% | $8.46 | 25 |
| 2024-Q4 | Increased | 98,519 | +1506.1% | $731,996 | 0.0% | $7.80 | 40 |
| 2024-Q3 | Increased | 6,134 | +71.2% | $58,273 | 0.0% | $9.40 | 21 |
| 2024-Q2 | Decreased | 3,583 | -53.5% | $44,680 | 0.0% | $12.47 | 0 |